Marvin L. Bayne, Ph.D.
Marvin Bayne is a drug discovery specialist with over 25 years of experience in the biotech and pharmaceutical industries. Marvin began his career at Unigene, working in the early stages of the biotech industry. He then led multiple projects in diabetes and endocrine research at Merck, before moving to Schering-Plough as head of genomics and discovery biotechnology. Marvin was Vice President of Discovery Technologies at the Schering-Plough Research Institute where he coordinated a department of enabling technologies including genomics, transgenic animal models of disease, high throughput screening and biomarker research. Currently, Marvin is a Research Fellow at the Charles A. Dana Research Institute for Scientists Emeriti (RISE) at Drew University. At RISE, Marvin runs a laboratory mentoring undergraduate researchers developing models of human diseases in the nematode, Caenorhabditis elegans. Marvin also consults with clients on strategies for building connections between early stage research in academia and development activities in the biotech industry. Marvin received his PhD in Molecular Biology and Biochemistry from Northwestern University and received postdoctoral training at the Johns Hopkins University.